Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Inspire Medical Systems stock

INSP
US4577301090
A2JLEP

Price

188.48
Today +/-
-0.59
Today %
-0.32 %

Inspire Medical Systems stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Inspire Medical Systems stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Inspire Medical Systems stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Inspire Medical Systems stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Inspire Medical Systems's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Inspire Medical Systems Stock Price History

DateInspire Medical Systems Price
12/27/2024188.48 undefined
12/26/2024189.09 undefined
12/24/2024186.29 undefined
12/23/2024187.58 undefined
12/20/2024187.77 undefined
12/19/2024185.42 undefined
12/18/2024186.97 undefined
12/17/2024190.71 undefined
12/16/2024188.83 undefined
12/13/2024187.83 undefined
12/12/2024190.00 undefined
12/11/2024192.77 undefined
12/10/2024189.42 undefined
12/9/2024189.52 undefined
12/6/2024193.03 undefined
12/5/2024191.60 undefined
12/4/2024196.92 undefined
12/3/2024191.90 undefined
12/2/2024188.52 undefined

Inspire Medical Systems Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Inspire Medical Systems, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Inspire Medical Systems from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Inspire Medical Systems’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Inspire Medical Systems. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Inspire Medical Systems’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Inspire Medical Systems’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Inspire Medical Systems’s growth potential.

Inspire Medical Systems Revenue, EBIT and net profit per share

DateInspire Medical Systems RevenueInspire Medical Systems EBITInspire Medical Systems Net Income
2029e1.74 B undefined303.01 M undefined212.56 M undefined
2028e1.54 B undefined218.31 M undefined162.32 M undefined
2027e1.34 B undefined162.15 M undefined116.85 M undefined
2026e1.14 B undefined96.93 M undefined97.2 M undefined
2025e970.55 M undefined49.72 M undefined61 M undefined
2024e812.01 M undefined20.7 M undefined40.49 M undefined
2023624.8 M undefined-40.27 M undefined-21.15 M undefined
2022407.9 M undefined-47.6 M undefined-44.9 M undefined
2021233.4 M undefined-39.9 M undefined-42 M undefined
2020115.4 M undefined-56.2 M undefined-57.2 M undefined
201982.1 M undefined-34.9 M undefined-33.2 M undefined
201850.6 M undefined-20.4 M undefined-21.8 M undefined
201728.6 M undefined-16 M undefined-17.5 M undefined
201616.4 M undefined-17.3 M undefined-18.5 M undefined
20158 M undefined-19.8 M undefined-21.3 M undefined

Inspire Medical Systems Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2015201620172018201920202021202220232024e2025e2026e2027e2028e2029e
0.010.020.030.050.080.120.230.410.620.810.971.141.341.541.74
-100.0075.0078.5764.0040.24102.6174.6853.3230.1319.4617.9416.7815.1912.80
62.5075.0078.5780.0082.9384.3585.8483.7884.6265.0254.4346.1539.5234.3130.41
51222406897200341528000000
-21-18-17-21-33-57-42-44-21406097116162212
--14.29-5.5623.5357.1472.73-26.324.76-52.27-290.4850.0061.6719.5939.6630.86
20.220.220.223.423.826.127.328.129.3000000
---------------
Details

Keystats

ⓘ

Revenue and Growth

The Inspire Medical Systems Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Inspire Medical Systems is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
20162017201820192020202120222023
               
6.716.1188.2149.5234.4214.5451.4460.38
2.13.96.713.125.134.261.289.88
00000000
3.43.72.75.88.517.211.933.89
0.10.41.72.222.75.59.6
12.324.1199.3170.6270268.6530593.74
0.910.8411.116.424.162.65
0006.309.909.14
00000000
00000000
00000000
0000.40.20.210.711.28
0.910.810.711.326.534.883.07
13.225.1200.1181.3281.3295.1564.8676.81
               
94.1119.1000000.03
6.87.3310.9319.9467508.5820.3917.11
-107.6-125.1-146.9-180.2-237.3-279.4-324.3-345.42
00-1001000-100-100800
00000000
-6.71.3163.9139.8229.7229495.9572.51
1.233.44.57.211.726.838.84
2.84.17.712.413.520.534.339.27
00000000
00000000
3.300009.200
7.37.111.116.920.741.461.178.1
12.416.524.924.524.715.800
00000000
0.10.20068.97.726.19
12.516.724.924.530.724.77.726.19
19.823.83641.451.466.168.8104.3
13.125.1199.9181.2281.1295.1564.7676.81
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Inspire Medical Systems provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Inspire Medical Systems's financial health and stability.

Assets

Inspire Medical Systems's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Inspire Medical Systems must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Inspire Medical Systems after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Inspire Medical Systems's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (k)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201520162017201820192020202120222023
-21-18-17-21-33-57-42-44-21
000000112
000000000
-1,000000-6,000-10,000-6,0001,000-40,000
0003122753104166
111221120
000000000
-22-17-15-18-32-53-201124
0000-2-2-4-9-23
230-7-83-438629-19-294
230-7-83-408933-10-271
000000000
2008000-240
0122518221341425931
2122519011341423513
---------17.00
000000000
3-5288-7416723227-256
-22.6-18.26-16.2-18.94-35.59-55.51-24.792.471.02
000000000

Inspire Medical Systems stock margins

The Inspire Medical Systems margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Inspire Medical Systems. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Inspire Medical Systems.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Inspire Medical Systems's sales revenue. A higher gross margin percentage indicates that the Inspire Medical Systems retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Inspire Medical Systems's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Inspire Medical Systems's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Inspire Medical Systems's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Inspire Medical Systems. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Inspire Medical Systems's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Inspire Medical Systems Margin History

Inspire Medical Systems Gross marginInspire Medical Systems Profit marginInspire Medical Systems EBIT marginInspire Medical Systems Profit margin
2029e84.54 %17.44 %12.24 %
2028e84.54 %14.19 %10.55 %
2027e84.54 %12.14 %8.75 %
2026e84.54 %8.47 %8.5 %
2025e84.54 %5.12 %6.28 %
2024e84.54 %2.55 %4.99 %
202384.54 %-6.45 %-3.39 %
202283.77 %-11.67 %-11.01 %
202185.73 %-17.1 %-17.99 %
202084.75 %-48.7 %-49.57 %
201983.31 %-42.51 %-40.44 %
201880.04 %-40.32 %-43.08 %
201778.67 %-55.94 %-61.19 %
201676.22 %-105.49 %-112.8 %
201565 %-247.5 %-266.25 %

Inspire Medical Systems Stock Sales Revenue, EBIT, Earnings per Share

The Inspire Medical Systems earnings per share therefore indicates how much revenue Inspire Medical Systems has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Inspire Medical Systems earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Inspire Medical Systems's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Inspire Medical Systems’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Inspire Medical Systems's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Inspire Medical Systems Revenue, EBIT and net profit per share

DateInspire Medical Systems Sales per ShareInspire Medical Systems EBIT per shareInspire Medical Systems Earnings per Share
2029e57.96 undefined0 undefined7.09 undefined
2028e51.35 undefined0 undefined5.42 undefined
2027e44.58 undefined0 undefined3.9 undefined
2026e38.17 undefined0 undefined3.24 undefined
2025e32.38 undefined0 undefined2.04 undefined
2024e27.09 undefined0 undefined1.35 undefined
202321.32 undefined-1.37 undefined-0.72 undefined
202214.52 undefined-1.69 undefined-1.6 undefined
20218.55 undefined-1.46 undefined-1.54 undefined
20204.42 undefined-2.15 undefined-2.19 undefined
20193.45 undefined-1.47 undefined-1.39 undefined
20182.16 undefined-0.87 undefined-0.93 undefined
20171.42 undefined-0.79 undefined-0.87 undefined
20160.81 undefined-0.86 undefined-0.92 undefined
20150.4 undefined-0.98 undefined-1.05 undefined

Inspire Medical Systems business model

Inspire Medical Systems Inc. is an American medical technology company that was founded in 2007 in Maple Grove, Minnesota. It focuses primarily on the development and production of implantable medical devices used in the treatment of sleep apnea. The company's business model is based on manufacturing and selling implantable devices, which are used by specially trained doctors. Inspire offers a comprehensive training program to educate doctors on the use of their devices and ensure optimal patient treatment. The company has had an impressive success story since its founding, with significant investments in research and development and the attainment of several patents. In summary, Inspire Medical Systems Inc. is an innovative company dedicated to the development and production of implantable medical devices for the treatment of sleep apnea. Its wide range of products and services aim to support doctors and patients, and the company is on track to become a leading provider in the industry. Inspire Medical Systems is one of the most popular companies on Eulerpool.com.

Inspire Medical Systems SWOT Analysis

Strengths

Inspire Medical Systems Inc possesses several strengths that contribute to its success and competitive advantage in the market:

  • Innovative and patented technology
  • Highly effective treatment for obstructive sleep apnea
  • Significant reduction in healthcare costs through long-term treatment benefits
  • Strong relationships with healthcare professionals and key opinion leaders
  • Robust sales and distribution network

Weaknesses

Despite its strengths, Inspire Medical Systems Inc faces certain weaknesses that it should address to maintain its market position:

  • Relatively high cost of treatment compared to alternative therapies
  • Dependency on reimbursement policies and insurance coverage
  • Limited market penetration in certain geographic regions
  • Requires a surgical procedure for permanent implantation
  • Need for ongoing patient compliance and follow-up

Opportunities

There are several opportunities that Inspire Medical Systems Inc can capitalize on to drive growth and expand its market presence:

  • Increasing prevalence of obstructive sleep apnea globally
  • Emerging markets with untapped potential for sleep apnea treatment
  • Technological advancements improving the efficacy and affordability of treatment
  • Partnerships with healthcare providers to enhance awareness and adoption
  • Expanding product portfolio to address related sleep disorders

Threats

Inspire Medical Systems Inc faces certain threats that may hinder its growth and competitive position:

  • Intense competition from alternative therapies and medical devices
  • Regulatory challenges and compliance requirements
  • Economic uncertainties impacting healthcare spending
  • Shifts in reimbursement policies and insurance coverage
  • Potential side effects or complications associated with the treatment

Inspire Medical Systems Revenue by Region

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Inspire Medical Systems Revenue by Segment

DateAll other countriesEuropeUnited States
202318.62 M USD-606.18 M USD
202213.02 M USD-394.83 M USD
202112.42 M USD-220.98 M USD
2020-9.27 M USD106.11 M USD
2019-8.39 M USD73.66 M USD
2018-6.22 M USD44.38 M USD
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Inspire Medical Systems Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Inspire Medical Systems historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Inspire Medical Systems shares outstanding

The number of shares was Inspire Medical Systems in 2023 — This indicates how many shares 29.302 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Inspire Medical Systems earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Inspire Medical Systems's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Inspire Medical Systems’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Inspire Medical Systems's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Inspire Medical Systems.

Inspire Medical Systems latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20240.08 0.6  (681.25 %)2024 Q3
6/30/2024-0.14 0.32  (325.04 %)2024 Q2
3/31/2024-0.66 -0.34  (48.86 %)2024 Q1
12/31/2023-0.09 0.49  (642.04 %)2023 Q4
9/30/2023-0.59 -0.29  (51.01 %)2023 Q3
6/30/2023-0.58 -0.41  (29.38 %)2023 Q2
3/31/2023-0.67 -0.53  (21.27 %)2023 Q1
12/31/2022-0.58 0.1  (117.33 %)2022 Q4
9/30/2022-0.78 -0.6  (23.2 %)2022 Q3
6/30/2022-0.63 -0.53  (15.94 %)2022 Q2
1
2
3

Eulerpool ESG Scorecard© for the Inspire Medical Systems stock

Eulerpool World ESG Rating (EESG©)

39/ 100

🌱 Environment

28

👫 Social

49

🏛️ Governance

39

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees48
Percentage of women in management
Percentage of Asian employees4.2
Share of Asian management
Percentage of Hispanic/Latino employees4.4
Hispano/Latino Management share
Percentage of Black employees3.2
Black Management Share
Percentage of white employees85.2
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Inspire Medical Systems shareholders

%
Name
Stocks
Change
Date
10.78458 % The Vanguard Group, Inc.3,232,138368,8039/30/2024
8.57753 % Fidelity Management & Research Company LLC2,570,685-1,287,6496/30/2024
6.59010 % Wellington Management Company, LLP1,975,05222,3946/30/2024
4.94338 % BlackRock Institutional Trust Company, N.A.1,481,53117,6776/30/2024
4.76088 % Baillie Gifford & Co.1,426,835-40,7786/30/2024
4.34764 % Wasatch Global Investors Inc1,302,989200,1226/30/2024
2.57061 % William Blair Investment Management, LLC770,41313,6026/30/2024
2.27967 % JP Morgan Asset Management683,216248,5146/30/2024
1.97550 % Macquarie Investment Management592,05633,5716/30/2024
1.96795 % State Street Global Advisors (US)589,79459,5946/30/2024
1
2
3
4
5
...
10

Inspire Medical Systems Executives and Management Board

Mr. Timothy Herbert

(60)
Inspire Medical Systems President, Chief Executive Officer, Director (since 2007)
Compensation 5.68 M

Mr. Bryan Phillips

(51)
Inspire Medical Systems Senior Vice President, Chief Compliance Officer, General Counsel, Company Secretary
Compensation 2.69 M

Mr. Randall Ban

(58)
Inspire Medical Systems Chief Commercial Officer (since 2019)
Compensation 2.21 M

Mr. Philip Ebeling

(52)
Inspire Medical Systems Chief Operating Officer
Compensation 2.15 M

Mr. Richard Buchholz

(55)
Inspire Medical Systems Chief Financial Officer
Compensation 2.13 M
1
2
3
4

Most common questions regarding Inspire Medical Systems

What values and corporate philosophy does Inspire Medical Systems represent?

Inspire Medical Systems Inc represents a commitment to improving the lives of individuals suffering from sleep apnea. Their corporate philosophy revolves around innovation, patient-centricity, and delivering effective and reliable solutions. By combining advanced technology with clinical expertise, Inspire Medical Systems Inc offers an innovative therapy that provides significant benefits to patients. The company emphasizes quality and excellence in everything they do, ensuring that their products meet the highest standards in terms of effectiveness and patient safety. With their dedication to improving the lives of those affected by sleep apnea, Inspire Medical Systems Inc strives to be a leader in the field of medical device solutions.

In which countries and regions is Inspire Medical Systems primarily present?

Inspire Medical Systems Inc primarily operates in the United States and Europe. The company's innovative products and therapies are focused on treating obstructive sleep apnea (OSA). Through their unique airway stimulation technology, Inspire Medical Systems Inc provides solutions to help patients with OSA improve their sleep quality and overall well-being. With a strong presence in these key regions, Inspire Medical Systems Inc continues to expand its reach and provide effective treatment options for individuals suffering from sleep apnea.

What significant milestones has the company Inspire Medical Systems achieved?

Some significant milestones achieved by Inspire Medical Systems Inc include the successful completion of multiple clinical trials and obtaining FDA approval for their innovative Inspire therapy. The company has also undergone successful IPOs and has expanded its market presence globally. Moreover, Inspire Medical Systems Inc has received numerous awards and recognitions for their revolutionary advancements in the treatment of obstructive sleep apnea. These milestones showcase the company's commitment to innovation, improving patient outcomes, and establishing itself as a leader in the medical technology industry.

What is the history and background of the company Inspire Medical Systems?

Inspire Medical Systems Inc, a renowned medical technology company, was founded in 2007 by Professor Philip R. Westbrook and Dr. Timothy A. Meyer. The company is headquartered in Maple Grove, Minnesota, USA. Inspire Medical Systems is dedicated to developing innovative solutions for the treatment of obstructive sleep apnea (OSA). The company introduced the Inspire therapy, an FDA-approved neurostimulation technology that provides a safe and effective alternative to traditional OSA treatments. With a mission to enhance the quality of life for patients suffering from OSA, Inspire Medical Systems has gained recognition as a leader in the field of sleep apnea treatment solutions.

Who are the main competitors of Inspire Medical Systems in the market?

The main competitors of Inspire Medical Systems Inc in the market include Medtronic, Inc., Intuitive Surgical, Inc., ResMed Inc., and Fisher & Paykel Healthcare Corporation Limited.

In which industries is Inspire Medical Systems primarily active?

Inspire Medical Systems Inc is primarily active in the medical device industry.

What is the business model of Inspire Medical Systems?

The business model of Inspire Medical Systems Inc revolves around providing innovative solutions for obstructive sleep apnea (OSA) treatment. The company specializes in the development and commercialization of advanced medical devices, particularly the Inspire therapy system. This implantable device delivers mild electrical stimulation to the hypoglossal nerve, keeping the airway open during sleep and effectively reducing OSA symptoms. Through its unique business model, Inspire Medical Systems aims to improve the quality of life for individuals with sleep apnea by offering a breakthrough treatment option that can significantly alleviate symptoms and enhance overall sleep health.

What is the P/E ratio of Inspire Medical Systems 2024?

The Inspire Medical Systems P/E ratio is 136.41.

What is the P/S ratio of Inspire Medical Systems 2024?

The Inspire Medical Systems P/S ratio is 6.8.

What is the Quality Investing of Inspire Medical Systems?

The Quality Investing for Inspire Medical Systems is 2/10.

What is the revenue of Inspire Medical Systems 2024?

The expected Inspire Medical Systems revenue is 812.01 M USD.

How high is the profit of Inspire Medical Systems 2024?

The expected Inspire Medical Systems profit is 40.49 M USD.

What is the business model of Inspire Medical Systems

Inspire Medical Systems Inc is a leading provider of innovative medical products for the treatment of sleep apnea. The company is headquartered in Minneapolis, MN and was founded in 2007. It is listed on the New York Stock Exchange (NYSE: INSP). Inspire Medical Systems offers an innovative therapy that uses selective neurostimulation to open the patient's airways during sleep and regulate breathing. The Inspire system consists of a small, implantable stimulation unit that is attached to the chest muscle, a sensor implanted in the chest muscle, and a remote control that the patient uses to turn the system on and off. The company holds a variety of patents in this field and works closely with leading doctors and sleep experts to ensure the effectiveness and safety of the system. The Inspire system is currently available in the United States, Canada, and Europe. In addition to the main product of the Inspire system, the company also offers a variety of therapy and support services to help patients with their sleep apnea treatment. These services include telephone support, training programs, and assistance with billing. Inspire Medical Systems' business model is based on a highly focused market approach. The company targets patients who suffer from severe sleep apnea and have not had success with conventional treatment methods, such as CPAP therapy. Based on market research data, the company estimates that there are up to 2 million potential patients in the US alone who could benefit from the Inspire system. Inspire Medical Systems has also focused on an intensive sales strategy. The company has built a distribution structure that aims to collaborate closely with sleep centers to promote the adoption and use of the system. An important part of this strategy is training doctors and medical staff to ensure they are familiar with the system and can apply it correctly. In terms of financial performance, Inspire Medical Systems has solid indicators. In 2019, the company reported revenue of $162.5 million, a 65% increase from the previous year. The company's success is also reflected in its market capitalization, which is approximately $4 billion. Overall, the business model of Inspire Medical Systems is highly focused and targeted towards a niche in the healthcare market. The company has developed an innovative product and is intensifying its efforts to penetrate the market and promote the use of its system.

What is the Inspire Medical Systems dividend?

Inspire Medical Systems pays a dividend of 0 USD distributed over payouts per year.

How often does Inspire Medical Systems pay dividends?

The dividend cannot currently be calculated for Inspire Medical Systems or the company does not pay out a dividend.

What is the Inspire Medical Systems ISIN?

The ISIN of Inspire Medical Systems is US4577301090.

What is the Inspire Medical Systems WKN?

The WKN of Inspire Medical Systems is A2JLEP.

What is the Inspire Medical Systems ticker?

The ticker of Inspire Medical Systems is INSP.

How much dividend does Inspire Medical Systems pay?

Over the past 12 months, Inspire Medical Systems paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Inspire Medical Systems is expected to pay a dividend of 0 USD.

What is the dividend yield of Inspire Medical Systems?

The current dividend yield of Inspire Medical Systems is .

When does Inspire Medical Systems pay dividends?

Inspire Medical Systems pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Inspire Medical Systems?

Inspire Medical Systems paid dividends every year for the past 0 years.

What is the dividend of Inspire Medical Systems?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Inspire Medical Systems located?

Inspire Medical Systems is assigned to the 'Health' sector.

Wann musste ich die Aktien von Inspire Medical Systems kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Inspire Medical Systems from 12/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/29/2024.

When did Inspire Medical Systems pay the last dividend?

The last dividend was paid out on 12/29/2024.

What was the dividend of Inspire Medical Systems in the year 2023?

In the year 2023, Inspire Medical Systems distributed 0 USD as dividends.

In which currency does Inspire Medical Systems pay out the dividend?

The dividends of Inspire Medical Systems are distributed in USD.

All fundamentals about Inspire Medical Systems

Our stock analysis for Inspire Medical Systems Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Inspire Medical Systems Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.